A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception☆☆☆
Abstract
Background
This study evaluates the willingness of women presenting for emergency contraception (EC) to enroll in a study offering the copper intrauterine device (IUD) or oral levonorgestrel (LNG) and follows up the two groups for 6 months after EC administration to compare use of an effective method of contraception.
Study Design
This prospective observational study offered these two methods to women presenting for EC. The primary outcome was use of an effective method of contraception 6 months after presenting for EC.
Results
Thirty-four women (60%) chose oral LNG and 23 (40%) chose the copper IUD. One month after presenting for EC, 21 (96%) of 22 in the IUD group were still using the IUD and all 22 were using an effective method of contraception (efficacy ≥92%). In the LNG group, 13 (52%) of 25 were using an effective method of contraception (p<.001). At 6 months, 9 (69%) of 13 IUD users and 11 (52%) of 21 oral LNG EC users were using an effective method (p=NS).
Conclusion
Women presenting for EC were willing to enroll in a study offering the copper IUD or oral LNG.
Keywords: Emergency contraception, IUD, Oral levonorgestrel, Pilot study
To access this article, please choose from the options below
☆ This research was supported by an anonymous foundation. David Turok receives research support in the form of product from Duramed Pharmaceuticals and has served on an advisory board for Bayer Healthcare.
☆☆ The findings from this report were presented as a poster at Reproductive Health 2009 in Los Angeles, CA, USA, in September 2009.
PII: S0010-7824(10)00352-5
doi:10.1016/j.contraception.2010.06.001
© 2010 Elsevier Inc. All rights reserved.
